Tags: Drug.
Andexanet alfa (PRT064445 PRT4445) is a drug under investigation as a potential antidote for factor Xa inhibitors a group of anticoagulant (anti–blood clotting) drugs that includes rivaroxaban apixaban and edoxaban. It is being developed by Portola Pharmaceuticals.